Cargando…

IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway

Inhibitor of nuclear factor kappa‐B kinase subunit epsilon (IKBKE) plays critical roles in the proliferation, invasion, and epithelial‐mesenchymal transition (EMT) of glioblastoma (GBM). However, as an immune response factor, few studies have focused on the role of IKBKE in the glioblastoma‐mediated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Li, Guo, Gaochao, Li, Jiabo, Fan, Xiaoguang, Li, Tao, Tong, Luqing, Liu, Peidong, Wang, Xuya, Yuan, Feng, Yu, Shengping, Huang, Qiang, Yang, Xuejun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418810/ http://dx.doi.org/10.1002/ctm2.130

Ejemplares similares

ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
por: Tong, Luqing, et al.
Publicado: (2020)

CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
por: Wang, Xin, et al.
Publicado: (2021)

Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma
por: Yi, Li, et al.
Publicado: (2018)

TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
por: Li, Jiabo, et al.
Publicado: (2022)

Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
por: Xiong, Jinbiao, et al.
Publicado: (2021)

IKBKE regulates cell proliferation and epithelial–mesenchymal transition of human malignant glioma via the Hippo pathway
por: Lu, Jie, et al.
Publicado: (2017)

Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
por: Liu, Yang, et al.
Publicado: (2017)

Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses
por: Yuan, Feng, et al.
Publicado: (2019)

PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
por: Wang, Xuya, et al.
Publicado: (2022)

The decreased expression of IKBKE in systemic lupus erythematosus
por: Zhu, Tingting, et al.
Publicado: (2020)

IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function
por: Guo, Jian-Ping, et al.
Publicado: (2013)

Retraction: IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function
Publicado: (2023)

Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples
por: Yuan, Feng, et al.
Publicado: (2019)

Advances in IKBKE as a potential target for cancer therapy
por: Yin, Min, et al.
Publicado: (2019)

Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation
por: Tao, Zhennan, et al.
Publicado: (2018)

NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways
por: Ma, Haiwen, et al.
Publicado: (2018)

MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas
por: Wang, Qiang-Wei, et al.
Publicado: (2021)

Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder
por: Traks, Tanel, et al.
Publicado: (2015)

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma
por: Yang, Wenjing, et al.
Publicado: (2018)

Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4
por: Yi, Li, et al.
Publicado: (2019)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
por: Wang, Xin, et al.
Publicado: (2019)

Activated kinase screening identifies the IKBKE oncogene as a positive regulator of autophagy
por: Leonardi, Margherita, et al.
Publicado: (2018)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells
por: Huang, Yubao, et al.
Publicado: (2018)

Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
por: Cui, Xin, et al.
Publicado: (2020)

IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway
por: Bainbridge, Alex, et al.
Publicado: (2020)

Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
por: Zhao, Zhen, et al.
Publicado: (2020)

Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
por: Wang, Xin, et al.
Publicado: (2019)

IKBKE Upregulation is Positively Associated with Squamous Cell Carcinoma of the Lung In Vivo and Malignant Transformation of Human Bronchial Epithelial Cells In Vitro
por: Li, Wei, et al.
Publicado: (2015)

Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma
por: Choi, John, et al.
Publicado: (2021)

MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway
por: Wang, Lingyan, et al.
Publicado: (2017)

Protein kinase D3 regulates the expression of the immunosuppressive protein, PD-L1, through STAT1/STAT3 signaling
por: Cui, Bomiao, et al.
Publicado: (2020)

A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE
por: Sandling, Johanna K, et al.
Publicado: (2011)

IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells
por: Göktuna, Serkan Ismail
Publicado: (2022)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1
por: Jung, Mi-Yeon, et al.
Publicado: (2022)

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
por: Khaja, Azharuddin Sajid Syed, et al.
Publicado: (2017)

PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages
por: Zhu, Zhiyuan, et al.
Publicado: (2020)

B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated Immunosuppression
por: Hou, David, et al.
Publicado: (2023)

A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma
por: Yun, Debo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nnflp1pti22fpu8ji8a5svbct2